The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Josie E. Parker Andrew Warrilow |
| Publication date | September 15, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |